SCHEMBL8245374

SCHEMBL8245374

CCCCNc1cnn(-c2ccccc2)c(=O)c1NC(C)=O

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 6/20 0.66
▸ RAB9A P51151 6/20 0.66
▸ KDM4E B2RXH2 3/20 0.66
▸ LMNA P02545 4/20 0.45
▸ NPC1 O15118 3/20 0.45
▸ HPGD P15428 3/20 0.45
▸ ALDH1A1 P00352 3/20 0.45
▸ TP53 P04637 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ NFKB1 P19838 1/20 0.45
▸ NFKB2 Q00653 1/20 0.45
▸ RELA Q04206 1/20 0.45
▸ MAPT P10636 4/20 0.44
▸ NPSR1 Q6W5P4 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ CYP2C9 P11712 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ HTT P42858 2/20 0.43
▸ PKM P14618 2/20 0.40
▸ KMT2A Q03164 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8246044 0.93 RAB9A (0.56) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL8242081 0.82 SMN1; SMN2 (0.73) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL13942531 0.79 RAB9A (0.45) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL19000704 0.77 SMN1; SMN2 (0.70) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL13942533 0.77 RAB9A (0.43) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL13942552 0.76 RAB9A (0.41) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL4172546 0.75 SMN1; SMN2 (0.57) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL13942551 0.75 RAB9A (0.42) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL8243863 0.75 RAB9A (0.91) SMN1; SMN2RAB9AKDM4ELMNANPC1
SCHEMBL4173129 0.73 RAB9A (0.47) SMN1; SMN2RAB9AKDM4ELMNANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007014226-A2 COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATION AND STROKE THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) 2007-02-01 — — WO disclosed
Send feedback